Alder Biopharmaceutica Profile

USD 2.05  15.07%

Acquisition by John Latham of 60000 shares of Alder Biopharmaceutica subject to Rule 16b-3

Alder Biopharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by John Latham, Chief Scientific Officer, on March 7, 2018. This event was filed by Alder Biopharmaceuticals with SEC on 2018-02-21. Statement of changes in beneficial ownership - SEC Form 4. John Latham is currently serves as co-founder and chief scientific officer of Alder Biopharmaceutica [view details]   

Alder Biopharmaceutica Summary

Alder Biopharmaceuticals Inc (ALDR) is traded on NASDAQ General Markets in USA. It is located in WASHINGTON, U.S.A and employs 193 people. Alder Biopharmaceutica is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 960 M. Alder Biopharmaceuticals Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 67.84 M outstanding shares of which 7.45 M shares are presently shorted by private and institutional investors with about 7.35 trading days to cover. Alder BioPharmace currently holds about 276.24 M in cash with (226.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.07.
Check Alder Biopharmaceutica Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Redmile Group LlcCommon Shares6.5 M74.5 M
Vanguard Group IncCommon Shares5.4 M61.4 M
View Alder Biopharmaceutica Diagnostics

Selected Alder Biopharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Alder Biopharmaceutica Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 55% 
Equity ratings for Alder Biopharmaceuticals Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Alder BioPharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington. Alder Biopharmaceutica operates under Biotechnology classification in USA and traded on NASDAQ General Markets. It employs 193 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAlder Biopharmaceuticals Inc
CEORandall SchatzmanView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address11804 North Creek Parkway South
ExchangeNASDAQ General Markets
CIK Number01423824.0
Contact Number425 205 2900
CurrencyUSD - US Dollar

Did you try this?

Run Portfolio Diagnostics Now

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
Hide  View All  NextLaunch Portfolio Diagnostics


Alder Biopharmaceutica Analyst Recommendations
Target PriceAdvice# of Analysts
40.33Strong Buy6Odds
Alder Biopharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Alder Biopharmaceutica Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Alder Biopharmaceutica Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.95April 27, 2017
Alder Biopharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Alder Biopharmaceutica Corporate Directors
Deepa Pakianathan Independent Director, MBA
Bruce Montgomery Independent Director
Deepika Pakianathan Independent Director, MBA